Please ensure Javascript is enabled for purposes of website accessibility

Obamacare Falls Into Place, and Health Insurers Rejoice

By Brandy Betz - Apr 2, 2013 at 6:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The government formalized rates for Medicaid and Medicare. What does it mean for insurers?

The future of the Patient Protection and Affordable Care Act became clearer over the past few days. The government has formalized financial details pertaining to Medicare Advantage rate cuts and for the future Medicaid expansions.

Health insurers popped before market close Monday as investors awaited the Medicare Advantage announcement. The gains continued after Tuesday's open, with Humana (HUM 1.99%) and UnitedHealth Group (UNH 0.97%) leading the S&P 500 with gains of around 5% today.

What do the finalized decisions mean for the future of these government-sponsored plans?

Medicare Advantage rates rise
Medicare Advantage plans won't suffer the rate cuts in 2014 that the Centers for Medicare and Medicaid Services proposed in February. Participating insurers will instead receive a 3.3% increase in payment reimbursements.

The CMS previously proposed a slash, which sent Humana plummeting 10%. But opponents pointed out that the reduction was based on the assumption that Congress would approve a physician rate cut, which hadn't happened in the past decade.

Humana has the most reason to celebrate, since its Medicare Advantage segment accounted for 53% of overall revenues in 2012. But UnitedHealth purchased XLHealth last year to increase its Advantage presence. With so many factors still undecided, the rate finalization offered a rare bit of good news for insurers.

Medicaid funds secured
In other Obamacare news, the Department of Health and Human Services recently formalized federal Medicaid financing plans that put the feds on the hook for 100% of expansion costs for the first three years, starting in 2013. The payments will gradually decrease to the permanent rate of 90% by 2020.

The information matched the figures that HHS had touted for months as it tried to get more states onboard with the expansion. But the majority of states remain either on the fence or firmly opposed. Expansion would broaden the coverage umbrella to include patients below age 65 who have income that's 133% above the federal poverty level.

Many continue to pursue waivers that would allow for the use of federal money in purchasing private plans. The HHS has said the option remains and extended a waiver to Arizona. But other states have found that approval isn't guaranteed.

WellPoint (ANTM 1.58%) is positioned to benefit from the potential expansions thanks to the Amerigroup acquisition last year, which increased its Medicaid presence.

Foolish final thoughts
Health-care investors -- and wonks -- face an interesting few months of watching the ACA plans continue to fall into place. The Advantage rate turnaround should encourage some optimism. Potential Medicaid benefits for insurers will become somewhat clearer once more states make their decisions. But that could become a long wait, since there's not a deadline on opting in or out of the expansion.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

UnitedHealth Group Incorporated Stock Quote
UnitedHealth Group Incorporated
UNH
$507.11 (0.97%) $4.88
Anthem, Inc. Stock Quote
Anthem, Inc.
ANTM
$520.55 (1.58%) $8.12
Humana Inc. Stock Quote
Humana Inc.
HUM
$461.21 (1.99%) $8.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
356%
 
S&P 500 Returns
124%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.